Non-invasive routes for insulin administration: current state and perspectives
- 31 October 2006
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Drug Delivery
- Vol. 3 (6) , 763-770
- https://doi.org/10.1517/17425247.3.6.763
Abstract
Diabetes mellitus is a chronic disease that usually requires multiple insulin injections to achieve adequate glycaemic control. This represents a major cause of reduced compliance to treatment. Consequently, other routes for insulin administration have been explored. During recent years, much progress in the development of inhaled insulin has been made. Inhaled insulin has shown favourable properties, such as a rapid onset of action, improved bioavailability and good tolerability; thereby providing satisfaction and ease of administration. However, long-term safety of inhaled insulin needs to be assessed, and the cost would be higher than injectable insulin. Nasal, oral and transdermal insulins are undergoing early phases of pharmacological development. The purpose of this review is to describe the latest developments in the area of non-invasive routes for insulin delivery.Keywords
This publication has 32 references indexed in Scilit:
- EXUBERA®: Pharmaceutical Development of a Novel Product for Pulmonary Delivery of InsulinDiabetes Technology & Therapeutics, 2005
- Pulmonary insulin delivery by means of the Technosphere™ drug carrier mechanismExpert Opinion on Drug Delivery, 2005
- Pulmonary Insulin UpdateDiabetes Technology & Therapeutics, 2005
- Inhaled insulin for diabetes mellitusAmerican Journal of Health-System Pharmacy, 2005
- Inhaled InsulinsTreatments in Endocrinology, 2005
- Impact of Particle Size and Aerosolization Time on the Metabolic Effect of an Inhaled Insulin AerosolDiabetes Technology & Therapeutics, 2004
- Insulin analogues and their potential in the management of diabetes mellitusDiabetologia, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Über Inhalation von InsulinJournal of Molecular Medicine, 1924